Cargando…
The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials
Some cancers such as human breast cancer, prostate cancer, and lung cancer easily metastasize to bone, leading to osteolysis and bone destruction accompanied by a complicated microenvironment. Systemic administration of bisphosphonates (BP) or denosumab is the routine therapy for osteolysis but with...
Autores principales: | Cheng, Xi, Wei, Jinrong, Ge, Qi, Xing, Danlei, Zhou, Xuefeng, Qian, Yunzhu, Jiang, Guoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751395/ https://www.ncbi.nlm.nih.gov/pubmed/33336610 http://dx.doi.org/10.1080/10717544.2020.1856225 |
Ejemplares similares
-
Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis()
por: Tiedemann, Kerstin, et al.
Publicado: (2018) -
Small extracellular vesicles deliver osteolytic effectors and mediate cancer‐induced osteolysis in bone metastatic niche
por: Ma, Qinyu, et al.
Publicado: (2021) -
Sclerostin induced tumor growth, bone metastasis and osteolysis in breast cancer
por: Zhu, Menghai, et al.
Publicado: (2017) -
Acro-osteolysis
por: Thomas, Joe, et al.
Publicado: (2019) -
IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors
por: Jin, Qian, et al.
Publicado: (2021)